feed,title,long_url,short_url
SeekingAlpha,Kymera discloses new development program ahead of its first R&D Day,https://seekingalpha.com/news/3780711,
SeekingAlpha,Dosing underway in Emergent Bio's Phase 1 study of influenza vaccine candidate,https://seekingalpha.com/news/3780710,
SeekingAlpha,"ECB will slow emergency asset purchases in Q1, keeps rates unchanged",https://seekingalpha.com/news/3780709,
